Basic Information
Basic information for SNHG14-283-17aa-5
Peptide Name SNHG14-283-17aa-5
Genome Position chr15:25119677-25119727[+]
Species Human
Peptide Sequence MAFFFFSSTYTSVSFVE
Peptide Length 17
Unique No (SNHG14-210-17aa-5,SNHG14-223-17aa-1,SNHG14-224-17aa-1,SNHG14-227-17aa-4,SNHG14-230-17aa-3,SNHG14-231-17aa-3,SNHG14-232-17aa-5,SNHG14-235-17aa-6,SNHG14-236-17aa-6,SNHG14-238-17aa-3,SNHG14-239-17aa-3,SNHG14-242-17aa-3,SNHG14-248-17aa-1,SNHG14-249-17aa-5,SNHG14-251-17aa-4,SNHG14-254-17aa-5,SNHG14-255-17aa-7,SNHG14-257-17aa-2,SNHG14-263-17aa-5,SNHG14-268-17aa-5,SNHG14-269-17aa-7,SNHG14-270-17aa-1,SNHG14-272-17aa-5,SNHG14-274-17aa-4,SNHG14-275-17aa-2,SNHG14-276-17aa-5,SNHG14-277-17aa-5,SNHG14-278-17aa-3,SNHG14-279-17aa-3,SNHG14-280-17aa-2,SNHG14-281-17aa-3,SNHG14-282-17aa-6,SNHG14-287-17aa-3,SNHG14-288-17aa-1,SNHG14-289-17aa-3,SNHG14-293-17aa-2,SNHG14-297-17aa-8,SNHG14-298-17aa-6,SNHG14-300-17aa-1,SNHG14-301-17aa-2,SNHG14-302-17aa-3,SNHG14-303-17aa-5,SNHG14-304-17aa-3,SNHG14-309-17aa-1,SNHG14-311-17aa-6,SNHG14-312-17aa-1,SNHG14-313-17aa-6,SNHG14-314-17aa-3,SNHG14-315-17aa-8,SNHG14-318-17aa-2,SNHG14-319-17aa-3,SNHG14-321-17aa-5,SNHG14-322-17aa-4,SNHG14-323-17aa-5,SNHG14-324-17aa-9,SNHG14-325-17aa-5,SNHG14-330-17aa-2,SNHG14-332-17aa-6,SNHG14-333-17aa-6,SNHG14-334-17aa-1,SNHG14-335-17aa-3,SNHG14-338-17aa-6,SNHG14-340-17aa-3,SNHG14-342-17aa-3)
Grand Average of Hydropathicity 0.9824
Relative Molecular Mass 2285.55
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000224078;SNHG14
Transcript ID/Name ENST00000663026;SNHG14-283
Transcript Length 7146
Coding Ability 0.4068
DNA Sequence Corresponding to Peptide ATGGCCTTTTTCTTTTTCAGTAGTACATACACATCTGTGTCATTTGTTGAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :